China
AstraZeneca Expects Higher China Sales, Denies Spinoff Report
SG Tylor
AstraZeneca’s CEO Pascal Soriot has denied a report that the company is considering spinning off its China business, which is ...
Moderna to research and manufacture mRNA meds in China under $1B agreement
SG Tylor
Despite ongoing political tensions between the United States and China, foreign investments in the pharmaceutical sector are progressing in China. ...
For the treatment of people with refractory generalized myasthenia gravis, Soliris has received approval in China
SG Tylor
Source- Astrazeneca For the treatment of adult patients with refractory generalized myasthenia gravis (gMG) and anti-acetylcholine receptor (AChR) antibody positivity, ...
